IWA
GILD icon

IBEX Wealth Advisors’s Gilead Sciences GILD Stock Holding History

IBEX Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.98M Buy
15,711
+388
+3% +$51.1K 0.16% 88
2026
Q1 		$2.14M Sell
15,323
-53,231
-78% -$7.45M 0.2% 79
2025
Q4 		$8.41M Buy
68,554
+54,566
+390% +$6.63M 0.82% 36
2025
Q3 		$1.55M Buy
13,988
+1,318
+10% +$150K 0.15% 96
2025
Q2 		$1.4M Buy
+12,670
New +$1.35M 0.15% 92
2024
Q3 		– Sell
-35
Closed -$2.42K – 144
2024
Q2 		$2.42K Sell
35
-65,433
-100% -$4.37M ﹤0.01% 268
2024
Q1 		$5.62M Buy
65,468
+2,468
+4% +$190K 1.52% 28
2023
Q4 		$5.09M Buy
63,000
+788
+1% +$61.3K 1.11% 35
2023
Q3 		$4.66M Buy
+62,212
New +$4.79M 1.19% 33
2023
Q1 		$5.55M Buy
66,848
+1,380
+2% +$114K 1.44% 26
2022
Q4 		$5.62M Buy
65,468
+438
+0.7% +$34.7K 1.27% 29
2022
Q3 		$4.01M Sell
65,030
-139
-0.2% -$8.77K 1.04% 34
2022
Q2 		$4.03M Buy
65,169
+54,048
+486% +$3.35M 0.93% 40
2022
Q1 		$661K Buy
+11,121
New +$711K 0.13% 109
2020
Q2 		– Sell
-26,726
Closed -$2M – 99
2020
Q1 		$2M Buy
+26,726
New +$1.85M 0.78% 52
2017
Q1 		– Sell
-87
Closed -$6K – 184
2016
Q4 		$6K Buy
+87
New +$6.47K ﹤0.01% 353

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IBEX Wealth Advisors's GILD Position: Q2 2026 in Review

IBEX Wealth Advisors increased its Gilead Sciences (GILD) stake by 2.5% in Q2 2026, buying an estimated $51.1K and bringing the position to 15,711 shares worth $1.98M. The position accounts for 0.16% of the portfolio, ranked #88.

IBEX Wealth Advisors first reported a position in GILD in Q4 2016 and has held it in 16 quarters since. The position peaked at $8.41M in Q4 2025. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • IBEX Wealth Advisors held 15,711 shares of Gilead Sciences worth $1.98M as of Q2 2026.
  • IBEX Wealth Advisors bought 388 Gilead Sciences shares in Q2 2026, an estimated $51.1K.
  • Gilead Sciences made up 0.16% of IBEX Wealth Advisors's portfolio in Q2 2026, its #88 holding.
  • IBEX Wealth Advisors first reported a position in Gilead Sciences in Q4 2016 and has held it in 16 quarters since.
  • IBEX Wealth Advisors's Gilead Sciences position peaked at $8.41M in Q4 2025.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on IBEX Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.